Fengli Hu

机构：Chongqing Medical University

发表论文 50 篇 · 总被引 802 次 · h-index 9

代表论文

• PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers (2020 · Nanoscale Research Letters · 被引 36)
• Silencing <italic>KIF14</italic> reverses acquired resistance to sorafenib in hepatocellular carcinoma (2020 · Aging · 被引 15)
• Astragalus polysaccharides combined with Codonopsis pilosula polysaccharides modulates the physiological characteristics of trophoblasts via miR-92a-1–5p/CCR7 axis (2022 · Tissue and Cell · 被引 9)
• ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma (2024 · Cancer Letters · 被引 6)
• Identification of risk and prognostic factors for intrahepatic vascular invasion in patients with hepatocellular carcinoma: a population-based study (2023 · Translational Cancer Research · 被引 6)
• EGLN1 inhibition reverses angiogenesis impairment in hyperglycemia by activating autophagy (2025 · Scientific Reports · 被引 3)